WallStreetZenWallStreetZen

NASDAQ: DYAI
Dyadic International Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for DYAI

Based on 1 analyst offering 12 month price targets for Dyadic International Inc

Min Forecast
$6.00+325.53%
Avg Forecast
$6.00+325.53%
Max Forecast
$6.00+325.53%

Should I buy or sell DYAI stock?

Based on 1 analyst offering ratings for Dyadic International Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DYAI stock forecasts and price targets.

DYAI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-14

1 of 1

Forecast return on equity

Is DYAI forecast to generate an efficient return?

Company
N/A
Industry
154.62%
Market
89.47%

Forecast return on assets

Is DYAI forecast to generate an efficient return on assets?

Company
N/A
Industry
32.61%

DYAI earnings per share forecast

What is DYAI's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.19
Avg 2 year Forecast
-$0.32

DYAI revenue forecast

What is DYAI's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$7.5M+121.43%
Avg 2 year Forecast
$5.5M+63.47%
DYAI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DYAI revenue growth forecast

How is DYAI forecast to perform vs Biotechnology companies and vs the US market?

Company
1.8%
Industry
60.56%
Market
10.84%
DYAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DYAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DYAI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DYAI$1.41$6.00+325.53%Buy
DTIL$5.45$47.00+762.39%Buy
RNTX$1.91N/AN/A
LTRN$3.82N/AN/A
CELU$1.82N/AN/A
View Top Biotech Stocks

Dyadic International Stock Forecast FAQ

Is Dyadic International Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DYAI) stock is to Buy DYAI stock.

Out of 1 analyst, 0 (0%) are recommending DYAI as a Strong Buy, 1 (100%) are recommending DYAI as a Buy, 0 (0%) are recommending DYAI as a Hold, 0 (0%) are recommending DYAI as a Sell, and 0 (0%) are recommending DYAI as a Strong Sell.

If you're new to stock investing, here's how to buy Dyadic International stock.

What is DYAI's earnings growth forecast for 2025-2026?

(NASDAQ: DYAI) Dyadic International's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.8%.

Dyadic International's earnings in 2025 is -$6,330,077.On average, 2 Wall Street analysts forecast DYAI's earnings for 2025 to be -$5,621,980, with the lowest DYAI earnings forecast at -$9,468,599, and the highest DYAI earnings forecast at -$1,775,362.

In 2026, DYAI is forecast to generate -$9,468,599 in earnings, with the lowest earnings forecast at -$9,468,599 and the highest earnings forecast at -$9,468,599.

What is DYAI's revenue growth forecast for 2025-2026?

(NASDAQ: DYAI) Dyadic International's forecast annual revenue growth rate of 1.8% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Dyadic International's revenue in 2025 is $3,364,548.On average, 2 Wall Street analysts forecast DYAI's revenue for 2025 to be $220,440,814, with the lowest DYAI revenue forecast at $180,495,163, and the highest DYAI revenue forecast at $260,386,465.

In 2026, DYAI is forecast to generate $162,741,541 in revenue, with the lowest revenue forecast at $162,741,541 and the highest revenue forecast at $162,741,541.

What is DYAI's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: DYAI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 32.61%.

What is DYAI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DYAI price target, the average DYAI price target is $6.00, with the highest DYAI stock price forecast at $6.00 and the lowest DYAI stock price forecast at $6.00.

The Wall Street analyst predicted that Dyadic International's share price could reach $6.00 by Nov 14, 2025. The average Dyadic International stock price prediction forecasts a potential upside of 325.53% from the current DYAI share price of $1.41.

What is DYAI's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: DYAI) Dyadic International's current Earnings Per Share (EPS) is -$0.23. On average, analysts forecast that DYAI's EPS will be -$0.19 for 2025, with the lowest EPS forecast at -$0.32, and the highest EPS forecast at -$0.06. In 2026, DYAI's EPS is forecast to hit -$0.32 (min: -$0.32, max: -$0.32).

What is DYAI's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: DYAI) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.